Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort
暂无分享,去创建一个
C. Jack | D. Harvey | M. Weiner | L. Beckett | Li Shen | A. Saykin | Sungeun Kim | J. West | S. Risacher | B. McDonald | Li Shen | John D. West | L. Shen
[1] A. Saykin,et al. Neuroimaging of Alzheimer’s Disease, Mild Cognitive Impairment, and Other Dementias , 2011 .
[2] A. Dale,et al. Brain atrophy in healthy aging is related to CSF levels of Aβ1-42. , 2010, Cerebral cortex.
[3] D. A. Bennett,et al. Rate of entorhinal and hippocampal atrophy in incipient and mild AD: Relation to memory function , 2010, Neurobiology of Aging.
[4] A. Dale,et al. Multi-modal imaging predicts memory performance in normal aging and cognitive decline , 2010, Neurobiology of Aging.
[5] Joseph V. Hajnal,et al. A robust method to estimate the intracranial volume across MRI field strengths (1.5T and 3T) , 2010, NeuroImage.
[6] Jason H. Moore,et al. Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans , 2010, Alzheimer's & Dementia.
[7] C. Jack,et al. Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor‐based morphometry , 2010, Human brain mapping.
[8] Nick C Fox,et al. Volume changes in Alzheimer’s disease and mild cognitive impairment: cognitive associations , 2010, European Radiology.
[9] Li Shen,et al. Comparison of Manual and Automated Determination of Hippocampal Volumes in MCI and Early AD , 2010, Brain Imaging and Behavior.
[10] A. Dale,et al. CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease , 2010, The Journal of Neuroscience.
[11] Nick C Fox,et al. The clinical use of structural MRI in Alzheimer disease , 2010, Nature Reviews Neurology.
[12] C. Jack,et al. Alzheimer's Disease Neuroimaging Initiative (ADNI) , 2010, Neurology.
[13] P. Scheltens,et al. Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial , 2010, Alzheimer's & Dementia.
[14] A. Dale,et al. Subregional neuroanatomical change as a biomarker for Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.
[15] Norbert Schuff,et al. Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: An ADNI study of 515 subjects , 2009, NeuroImage.
[16] Nick C. Fox,et al. A meta-analysis of hippocampal atrophy rates in Alzheimer's disease , 2009, Neurobiology of Aging.
[17] A. Dale,et al. Structural MRI biomarkers for preclinical and mild Alzheimer's disease , 2009, Human brain mapping.
[18] A. Dale,et al. Regional rates of neocortical atrophy from normal aging to early Alzheimer disease , 2009, Neurology.
[19] Li Shen,et al. Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort , 2009, Current Alzheimer research.
[20] C. Jack,et al. MRI and CSF biomarkers in normal, MCI, and AD subjects , 2009, Neurology.
[21] C. Davatzikos. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI , 2009, Alzheimer's & Dementia.
[22] A. Saykin,et al. Genetic predictors of 12-month change in MRI hippocampal volume in the Alzheimer's Disease Neuroimaging Initiative cohort: Analysis of leading candidates from the AlzGene database , 2009, Alzheimer's & Dementia.
[23] H. Benali,et al. Fully automatic hippocampus segmentation and classification in Alzheimer's disease and mild cognitive impairment applied on data from ADNI , 2009, Hippocampus.
[24] Michael Weiner,et al. Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls , 2009, NeuroImage.
[25] J. Pariente,et al. Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve , 2009, Brain : a journal of neurology.
[26] Alzheimer's Disease Neuroimaging Initiative,et al. Alzheimer's Disease Neuroimaging Initiative: A one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition , 2009, NeuroImage.
[27] A. Dale,et al. Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. , 2009, Radiology.
[28] Pei-Ning Wang,et al. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment , 2009, Psychiatry Research: Neuroimaging.
[29] C. Jack,et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease , 2009, Brain : a journal of neurology.
[30] Norbert Schuff,et al. Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls , 2009, NeuroImage.
[31] Christos Davatzikos,et al. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI , 2009, NeuroImage.
[32] R. Tanzi,et al. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses , 2008, Nature Reviews Neuroscience.
[33] R. Bartha,et al. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. , 2008, Brain : a journal of neurology.
[34] C. Jack,et al. Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI , 2008, Neurobiology of Aging.
[35] Andrew J. Saykin,et al. AbstractPoster presentation: Imaging posterIC-P1-054: Comparison of manual and automated determination of hippocampal volumes in MCI and older adults with cognitive complaints , 2008 .
[36] S Lehéricy,et al. VBM anticipates the rate of progression of Alzheimer disease , 2008, Neurology.
[37] C. Jack,et al. MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers , 2008, Brain : a journal of neurology.
[38] Nick C Fox,et al. Whole-brain atrophy rate in Alzheimer disease , 2008, Neurology.
[39] C. Jack,et al. Atrophy rates accelerate in amnestic mild cognitive impairment , 2008, Neurology.
[40] Nick C Fox,et al. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.
[41] C. Jack,et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.
[42] H. Soininen,et al. Apolipoprotein E ε4 Allele Is Associated with Increased Atrophy in Progressive Mild Cognitive Impairment: A Voxel-Based Morphometric Study , 2008, Neurodegenerative Diseases.
[43] et al.,et al. Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline , 2008, NeuroImage.
[44] C. Jack,et al. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment , 2008, Neurology.
[45] Jennifer L. Whitwell,et al. Rates of brain atrophy over time in autopsy-proven frontotemporal dementia and Alzheimer disease , 2008, NeuroImage.
[46] C. Jack,et al. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment , 2008, Neurology.
[47] Nick C Fox,et al. Automatic calculation of hippocampal atrophy rates using a hippocampal template and the boundary shift integral , 2007, Neurobiology of Aging.
[48] R. Mayeux,et al. Hippocampal and entorhinal atrophy in mild cognitive impairment , 2007, Neurology.
[49] K. Blennow,et al. Imaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's Disease , 2007, Annals of the New York Academy of Sciences.
[50] Andrew J. Saykin,et al. Hippocampal Volume and Shape Analysis in an Older Adult Population , 2007, The Clinical neuropsychologist.
[51] J. Lirng,et al. Prediction of Alzheimer's disease in mild cognitive impairment: A prospective study in Taiwan , 2006, Neurobiology of Aging.
[52] N. Schuff,et al. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. , 2006, Brain : a journal of neurology.
[53] Taylor W. Schmitz,et al. Structural MRI discriminates individuals with Mild Cognitive Impairment from age-matched controls: A combined neuropsychological and voxel based morphometry study , 2006, Alzheimer's & Dementia.
[54] A. Saykin,et al. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI , 2006, Neurology.
[55] M. Filippi,et al. The contribution of voxel-based morphometry in staging patients with mild cognitive impairment , 2006, Neurology.
[56] Kiralee M. Hayashi,et al. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. , 2006, Archives of neurology.
[57] N. Schuff,et al. Age effects on atrophy rates of entorhinal cortex and hippocampus , 2006, Neurobiology of Aging.
[58] L. Fratiglioni,et al. Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.
[59] J. Kaye,et al. Brain volume loss in MCI predicts dementia , 2006, Neurology.
[60] C. Mathers,et al. Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.
[61] C. Jack,et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI , 2005, Neurology.
[62] Brigitte Landeau,et al. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study , 2005, NeuroImage.
[63] N. Schuff,et al. Longitudinal volumetric MRI change and rate of cognitive decline , 2005, Neurology.
[64] C. Jack,et al. Ways toward an early diagnosis in Alzheimer’s disease: The Alzheimer’s Disease Neuroimaging Initiative (ADNI) , 2005, Alzheimer's & Dementia.
[65] Charles DeCarli,et al. Sex, Apolipoprotein E ε4 Status, and Hippocampal Volume in Mild Cognitive Impairment , 2005 .
[66] Karl J. Friston,et al. Voxel-based morphometry of the human brain: Methods and applications , 2005 .
[67] G. Frisoni,et al. A voxel based morphometry study on mild cognitive impairment , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[68] Paul M. Thompson,et al. Mapping hippocampal and ventricular change in Alzheimer disease , 2004, NeuroImage.
[69] H. Soininen,et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD , 2004, Neurobiology of Aging.
[70] C. Jack,et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD , 2004, Neurology.
[71] N. Schuff,et al. Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia , 2003, Neurobiology of Aging.
[72] Emma J. Burton,et al. A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry , 2003, NeuroImage.
[73] B. Winblad,et al. The Magnitude of Dementia Occurrence in the World , 2003, Alzheimer disease and associated disorders.
[74] Griselda J. Garrido,et al. A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer’s disease , 2003, Neurobiology of Aging.
[75] G. Frisoni,et al. Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry , 2002, Journal of neurology, neurosurgery, and psychiatry.
[76] J. Baron,et al. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment , 2002, Neuroreport.
[77] M. Albert,et al. MRI measures of entorhinal cortex vs hippocampus in preclinical AD , 2002, Neurology.
[78] P. Scheltens,et al. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment , 2002, Journal of neurology, neurosurgery, and psychiatry.
[79] Hiroaki Kazui,et al. Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E ε4 allele , 2002 .
[80] A. Dale,et al. Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.
[81] J. Morris,et al. Current concepts in mild cognitive impairment. , 2001, Archives of neurology.
[82] N. Schuff,et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.
[83] D. Bennett,et al. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease☆ ☆ This research was supported by grants P01 AG09466 and P30 AG10161 from the National Institute on Aging, National Institutes of Health. , 2001, Neurobiology of Aging.
[84] K M Heilman,et al. Anomalous anatomy of speech–language areas in adults with persistent developmental stuttering , 2001, Neurology.
[85] Karl J. Friston,et al. A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.
[86] A M Dale,et al. Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[87] C. Jack,et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD , 2000, Neurology.
[88] D. Bennett,et al. From Healthy Aging to Early Alzheimer's Disease: In Vivo Detection of Entorhinal Cortex Atrophy , 2000, Annals of the New York Academy of Sciences.
[89] Karl J. Friston,et al. Voxel-Based Morphometry—The Methods , 2000, NeuroImage.
[90] C. Jack,et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD , 2000, Neurology.
[91] R. Petersen,et al. Mild cognitive impairment: transition between aging and Alzheimer's disease. , 2000, Neurologia.
[92] C. Jack,et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.
[93] A. Dale,et al. Cortical Surface-Based Analysis II: Inflation, Flattening, and a Surface-Based Coordinate System , 1999, NeuroImage.
[94] Anders M. Dale,et al. Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.
[95] Nick C Fox,et al. Brain atrophy progression measured from registered serial MRI: Validation and application to alzheimer's disease , 1997, Journal of magnetic resonance imaging : JMRI.
[96] J. Haines,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.
[97] J. Haines,et al. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .
[98] E. Baráth,et al. Fundamentals of Biostatistics. , 1992 .
[99] C. Jack,et al. MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease , 1992, Neurology.
[100] P. Lachenbruch. Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .
[101] Jean-Luc Anton,et al. Region of interest analysis using an SPM toolbox , 2010 .
[102] Roberto Bellotti,et al. Automatic analysis of medial temporal lobe atrophy from structural MRIs for the early assessment of Alzheimer disease. , 2009, Medical physics.
[103] C. Jack,et al. 11 C PiB and structural MRI provide complementary information in imaging of Alzheimer ’ s disease and amnestic mild cognitive impairment , 2008 .
[104] A. Toga,et al. Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment. , 2006, Archives of neurology.
[105] Charles DeCarli,et al. Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. , 2005, Archives of neurology.
[106] F. Fazio,et al. Role of Integrated 18-F FDG PET/CT in Recurrent Ovarian Cancer , 2005 .
[107] Vladimir V. Frolkis,et al. Neurobiology of Aging , 2019, Psychobiology of Behaviour.
[108] Hiroaki Kazui,et al. Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele. , 2002, Annals of neurology.
[109] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .